Download full-text PDF

Source
http://dx.doi.org/10.1002/(sici)1521-3773(20000502)39:9<1679::aid-anie1679>3.0.co;2-4DOI Listing

Publication Analysis

Top Keywords

rhône poulenc
8
traceless solid-phase
4
solid-phase synthesis
4
synthesis biarylmethane
4
biarylmethane structures
4
structures pd-catalyzed
4
pd-catalyzed release
4
release supported
4
supported benzylsulfonium
4
benzylsulfonium salts
4

Similar Publications

Background: Clinical practice suggests that older adults (i.e., ≥ 65 years of age) experience adverse drug reactions (ADRs) more often than younger patients (i.

View Article and Find Full Text PDF

General loss of proteostasis links Huntington disease to Cockayne syndrome.

Neurobiol Dis

October 2024

Department of Dermatology and Allergic Diseases, University of Ulm, James-Franck Ring N27, 89081 Ulm, Germany. Electronic address:

Article Synopsis
  • Cockayne syndrome (CS) is a genetic disorder causing developmental delays, multiple organ issues, and symptoms resembling premature aging.
  • The study found that CS shares significant gene expression characteristics with neurodegenerative diseases, particularly Huntington's disease (HD), highlighting disruptions in ribosomal biogenesis and protein stability in CS patient cells.
  • Research using cell models demonstrated that the mutant form of the Huntingtin protein in HD leads to similar problems in ribosomal function and overall protein homeostasis, suggesting a common pathway in neurodegeneration between CS and HD.
View Article and Find Full Text PDF

Twenty-Three Years of Declining Lithium Use: Analysis of a Pharmacoepidemiological Dataset from German-Speaking Countries.

Pharmacopsychiatry

November 2024

Department of Psychiatry, Psychotherapy and Psychosomatics, Hospital of Psychiatry, University of Zurich, Zurich, Switzerland.

Introduction: Pharmacoepidemiological data suggest that lithium prescriptions for bipolar disorder are gradually decreasing, with less attention having been paid to other indications.

Methods: We examined lithium prescriptions between 1994 and 2017 in data provided by the Drug Safety in Psychiatry Program AMSP, including psychiatric hospitals in Germany, Austria and Switzerland. We compared lithium use for different diagnoses before and after 2001 and in three periods (T1: 1994-2001, T2: 2002-2009, and T3: 2010-2017).

View Article and Find Full Text PDF

Increasing appreciation of the phenotypic and biological overlap between amyotrophic lateral sclerosis (ALS) and frontotemporal dementia, alongside evolving biomarker evidence for a pre-symptomatic stage of disease and observations that this stage of disease might not always be clinically silent, is challenging traditional views of these disorders. These advances have highlighted the need to adapt ingrained notions of these clinical syndromes to include both the full phenotypic continuum - from clinically silent, to prodromal, to clinically manifest - and the expanded phenotypic spectrum that includes ALS, frontotemporal dementia and some movement disorders. The updated clinical paradigms should also align with our understanding of the biology of these disorders, reflected in measurable biomarkers.

View Article and Find Full Text PDF

Objective: There are few effective osteoarthritis (OA) therapies. A novel injectable polyacrylamide hydrogel (iPAAG) previously demonstrated efficacy and safety up to week 26 in an open-label study of knee OA. Here we report longer-term effectiveness and safety data.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!